Pleco Therapeutics Announces Final Close Of Its Series A Financing Raising €17.3M To Progress Its Novel Plecoid™ Product In Acute Myeloid Leukaemia To Regulatory Filing In Usa And Eu
Amount Raised
€17.3 Million
Round Type
Series A
NijmegenBiotechnologyHealth CareTherapeuticsDescription
Pleco Therapeutics BV, a specialty biopharmaceutical company developing novel treatments designed to detoxify the cancer micro-environment today announces the final close of its Series A financing, with total funds raised of €17.3 million. The funds will be used to complete development and commercialise the Company's novel lead PlecoidTM Product, PTX-061, to improve the effectiveness of chemotherapy in patients with Acute Myeloid Leukaemia (AML).
Quick answer
Pleco Therapeutics raised €17.3 Million in a Series A round, dated September 6, 2022. Pleco Therapeutics is based in Nijmegen, Gelderland, Netherlands.
- How much did Pleco Therapeutics raise?
- Pleco Therapeutics raised €17.3 Million in a Series A round on September 6, 2022.
- What does Pleco Therapeutics do?
- Pleco Therapeutics is a clinical stage specialty pharmaceutical company which aims to extend the life span and enhance the quality of life of patients through its novel Plecoid™ therapies that have been designed to..
- Where is Pleco Therapeutics based and how big is it?
- Pleco Therapeutics is based in Nijmegen, Gelderland, Netherlands.
- Who are the decision-makers at Pleco Therapeutics?
- Fundz holds 1 contact at Pleco Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Pleco Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Orionis Biosciences raised $55M (Funding Round) on October 19, 2022.
- Insmed Incorporated raised an undisclosed amount (Funding Round) on October 19, 2022.
- SURGE Therapeutics raised $26M (Series A) on October 17, 2022.
- Mablink Bioscience raised $30M (Series A) on October 14, 2022.
- CTRL Therapeutics raised $7.5M on October 12, 2022.
- Neumora raised $112M (Series B) on October 11, 2022.
Who to call at Pleco Therapeutics, and when
A new round usually means Pleco Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Pleco Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Pleco Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Pleco Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Pleco Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansPleco Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.